Take a look at some of the biggest movers in the premarket:
Eli Lilly (LLY) – The drugmaker began testing a Covid-19 experimental treatment derived from the blood of a survivor of the disease. It is the first study involving this type of drug, and comes about a month earlier than expected and ahead of rival Regeneron (REGN), which expects to begin a similar study this month.
Coty (COTY) – Coty named chairman Peter Harf as CEO, with Harf becoming the cosmetics maker’s fourth CEO in less than four years. The announcement comes as Coty and KKR (KKR) sign a